http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-866785-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc2f7134efa50484bb359fda73782848
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-20
filingDate 1957-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1961-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-866785-A
titleOfInvention New sulphonamides and preparations containing them
abstract The invention comprises compounds of the general formula: <FORM:0866785/IV (b)/1> and salts of these compounds, in which R is hydrogen or a hydrocarbon, preferably alkyl, group of 1-6 carbon atoms. The compounds are prepared either by treating the corresponding 6-halogeno-3-sulphanilamido-pyridazine with a metal hydrosulphide such as sodium hydrosulphide or a mercaptan of the formula HSR, or by treating a compound which contains a nitro or acetylamino group in place of the p-amino group, by hydrogenation in the presence of a nickel catalyst in the case of the nitro compound, or by hydrolysis with caustic soda in the case of the acetylamino compound, to give the desired sulphanilamido derivative. The products are used therapeutically against coccal infections. Examples describe the preparation of the 3-sulphanilamido derivatives of 6-mercapto-, 6-methylthio-, 6-ethylthio- and 6-isoamylthio-, pyridazine. 3- p- Acetylaminobenzenesulphonamido- 6-ethylmercapto-pyridazine is made by the action of ethylmercaptan on 3-p-acetylaminobenzene-sulphonamido-6-chloropyridazine. Specification 866,786 is referred to.ALSO:Pharmaceutical preparations for treatment of coccal infections comprise sulphonamides of the formula <FORM:0866785/VI/1> wherein R is hydrogen or a hydrocarbon, preferably alkyl, group of 1-6 carbon atoms, e.g. methyl, ethyl or isoamyl, or a salt thereof, in admixture with a pharmaceutical carrier. The preparations may suitably take the form of tablets, dragees, powders, salves, creams, suppositories, solutions, suspensions or emulsions, for enteral, parenteral or local administration. Specified salts are those of alkali and alkaline-earth metals. Specification 866,786 is referred to.
priorityDate 1956-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522963
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9259
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28015
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449545084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393673
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6343
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412550040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5047209
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416290473
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393644

Total number of triples: 29.